What happens if you stop after receiving only one dose of the bivalent HPV vaccine?

Receiving only one dose of the bivalent HPV vaccine and not completing the remaining doses will reduce its protective effect against diseases. The detailed explanation is as follows:

The bivalent HPV vaccine is primarily used to prevent human papillomavirus (HPV) infection and cervical cancer, and is suitable for females aged 9 to 45. The full vaccination schedule requires three doses, all of which should be completed within six months, typically administered at month 0, month 2, and month 6. If only one dose is received and the series is not completed, the body may produce some antibodies, but the quantity will be insufficient. This fails to adequately stimulate the immune system to generate a proper immune response, resulting in inadequate antibody production. Consequently, the effectiveness of the bivalent HPV vaccine is compromised, and it cannot effectively protect against HPV infection or cervical cancer.

It is essential to follow the standard vaccination schedule for the bivalent HPV vaccine to ensure optimal preventive efficacy.